Barclays Notes the Payoffs From The Aetna & Coventry Deal – ValueWalk Premium

Barclays Notes the Payoffs From The Aetna & Coventry Deal

Barclays’ research review of the recent acquisition of Coventry Health Care, Inc. (NYSE:CVH) by Aetna Inc. (NYSE:AET) is highly appreciative of the merger.

Though the stock rating for Aetna Inc. (NYSE:AET) is maintained unchanged at Overweight, and so is the Price Target at $55, it would be useful to look at the many . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0